Parathyroid Carcinoma - Diagnosis and Surgical Treatment a 24-year Experience

• Authors: Jacek Gawrychowski , Grzegorz Kowalski , Grzegorz Buła
• Languages of publication: EN

Abstracts

EN

The aim of the study was to evaluate the clinical, surgical and pathological prognostic factors of postoperative disease progression in parathyroid cancer patients.Material and methods. This is a retrospective study of 19 patients operated on between 1983 and 2007 for parathyroid cancer at the Department of General Surgery of the Silesian Medical University constituting 4.6% of the total 416 patients operated on during that time for primary hyperparathyroidism.Results. The study is based on a group of 7 (27%) men and 12 (63%) women aged 27 - 77 (av. 56). On admission, serum calcium levels exceeding 3.5 mmol/L were observed in 11 (58%) patients with parathyroid cancer and in 4 (1%) of the 397 patients with benign changes. Serum parathormone (PTH) levels higher than 450 pg/ml were found in 9 (47.4%) and 11 (2.8%) patients, respectively. Whenever parathyroid cancer was suspected, an en block resection of the parathyroid tumor including a wide margin of adjacent tissue was performed. Ipsilateral thyroid lobectomy was performed on 14 patients but in 5 cases total thyreoidectomy was required. 14 (73.7%) patients underwent either ipsilateral (11x) or bilateral (3x) lymphadenectomy. Within the group of 19 patients a total of 41 operations were required, including 4 operations in other medical centers. Three patients underwent adjuvant radiation therapy. The cumulative postoperative 5-, 10- and 15-year survival rate for the 19 parathyroid cancer patients was 95%, 82.5% and 62% respectively. Local and/or regional recurrences as well as remote metastases were found in 7 and 6 patients, respectively. Of the former group six patients are still alive after 3, 7, 9, 10, and - in two cases - 12 years (the 7th patient died 14 years after the first operation). Of the latter group three patients died of cancer dissemination 5, 7 and 8 years after the initial operation, but three others are still alive after 7, 10 and 14 years while still displaying the disease symptoms. Six patients, all of whom underwent one-stage resection of parathyroid glands and both ipsilateral thyroid lobectomy and lymphadenectomy, are still alive 8, 10, 11, 13, 14 and 21 years after with no evidence of the disease.Conclusions. 1. Parathyroid cancer should always be suspected while dealing with primary hyperparathyroidism in patients with significantly elevated serum calcium and PTH levels. 2. Ipsilateral lymphadenectomy is advocated for parathyroid cancer patients already during the initial operation. 3. In order to avoid parathyroid cancer relapse even many years after the surgery, periodic checks are recommended for the rest of the patients' lives.

Keywords

EN

primary hyperparathyroidism; parathyroid cancer

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2010
• Volume: 82
• Issue: 2
• Pages: 88-94

Dates

published

1 - 2 - 2010

online

18 - 3 - 2010

Contributors

author

Jacek Gawrychowski

• Department of General Surgery in Bytom, Silesian Medical University in Katowice

author

Grzegorz Kowalski

• Department of General Surgery in Bytom, Silesian Medical University in Katowice

author

Grzegorz Buła

• Department of General Surgery in Bytom, Silesian Medical University in Katowice

References

• Fraker DL: Update on the management of parathyroid tumors. Curr Opin Oncol 2000; 12: 41-48.[Crossref][PubMed]
• Agrawal R, Agrawal A, Kar DK et al.: Parathyroid carcinoma. J Assoc Physicians India 2001; 49: 990-93.[PubMed]
• Castillo L, Poissonnet G, Haddad A et al.: Parathyroid carcinoma: diagnosis and treatment. Rev Laryngol Otol Rhinol 2000; 121: 169-73.
• Shane E: Clinical review 122: Parathyroid Carcinoma. J Clin Endocrinol Metab 2001; 86: 485-93.
• Hundahl SA, Fleming ID, Fremgen AM et al.: Two Hundred Eighty-Six Cases of Parathyroid Carcinoma Treated in the U. S. between 1985-1995: a National Cancer Date Base report. Cancer 1999; 86: 538-44.
• Snell SB, Gaar EE, Stevens SP et al.: Parathyroid cancer, a continued diagnostic and therapeutic dilemma: report of four cases and review of the literature. Am Surg 2003; 69: 711-16.[PubMed]
• Babar-Craig H, Quaglia A, Stearns M: Parathyroid carcinoma: a report of two cases and a concise review and update of the literature. J Laryngol Otol 2005; 119: 577-80.
• Clark P, Wooldridge T, Kleinpeter K et al.: Providing Optimal Preoperative Localization for Recurrent Parathyroid Carcinoma: A Combined Parathyroid Scintigraphy and Computed Tomography Approach. Clin Nucl Med 2004; 29: 681-84.[Crossref][PubMed]
• Suliburk JW, Perrier ND: Primary Hyperparathyroidism. Oncologist 2007; 12: 644-653.[WoS][Crossref][PubMed]
• Rawat N, Khetan N, Williams DW et al.: Parathyroid carcinoma. Brit J Surg 2005; 92: 1345-53.[Crossref]
• Pelizzo MR, Piotto A, Bergamasco A et al.: Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience. Minerva Endocrinol 2001; 26: 23-29.[PubMed]
• Chang YJ, Mittal V, Remine S et al.: Correlation Between Clinical and Histological Findings in Parathyroid Tumors Suspicious for Carcinoma. Am Surg 2006; 72: 419-26.
• Dedeurwaerdere F, Van Damme B: Histopathology of parathyroid glands. Acta Otorhinolaryngol Belg 2001; 55: 95-101.[PubMed]
• Tsyb AF, Shakhtarin, Lushnikov EF et al.: Development of cancer and non-cancer thyroid diseases in children and adolescents after the Chernobyl accident. In: Thomas G, Karaoglou A, Williams ED (eds) Radiation and thyroid cancer. World Scientific, Singapore 1999; 79-87.
• Kleinpeter KP, Lovato JF, Clark PB et al.: Is Parathyroid Carcinoma Indeed a Lethal Disease. Ann Surg Oncol 2005; 12: 260-66.[Crossref][PubMed]
• Rosman PM, Sutton JB, Brys DA: Parathyroid Carcinoma Metastasis Presenting as a Pathologic Bone Fracture. Orthopedics 2006; 29: 549-51.[PubMed]
• Thompson SD, Prichard AJ: The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 93-97.[PubMed][Crossref]
• Ippolito G, Palazzo FF, Sebag F et al.: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg 2007; 94: 566-70.
• Dionisi S, Minisola S, Pepe J et al.: Concurrent Parathyroid Adenomas and Carcinoma In the Setting of Multiple Endocrine Neoplasia Type 1: Presentation as Hypercalcemic Crisis. Mayo Clin Proc 2002; 77: 866-69.
• Inabnet III WB, Dakin GF, Haber RS et al.: Targeted Parathyroidectomy in the Era of Intraoperative Parathormone Monitoring. World J Surg 2002; 26: 921-25.[Crossref]
• Hoelting T, Weber T, Werner J et al.: Surgical treatment of parathyroid carcinoma. Oncol Rep 2001; 8: 931-34.
• Kirby-Bott J, Lewis P, Harmer CL et al.: One stage treatment of parathyroid cancer. Eur J Surg Oncol 2005; 31: 78-83.
• Chow E, Tsang RW, Brierley JD et al.: Parathyroid carcinoma-the Princess Margaret Hospital experience. Int J Radiot Oncol Biol Phys 1998; 41: 569-72.[Crossref]
• Kebebew E, Arici C, Duh QY et al.: Localization and Reoperation Results for Persistent and Recurrent Parathyroid Carcinoma. Arch Surg 2001; 136: 878-85.
• Thompson SD, Prichard AJN: The management of parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 93-97.[PubMed][Crossref]
• Wiseman SM, Rigual NR, Hicks WL et al.: Parathyroid carcinoma: A multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J 2004; 83: 491-94.[PubMed]
• Montenegro FL, Tavares MR, Durazzo MD et al.: Clinical suspicion and parathyroid carcinoma management. Sao Paulo Med J 2006; 124: 42-44.[PubMed]
• Munson N, Foote R, Northcutt R et al.: Parathyroid Carcinoma: Is There a Role for Adjuvant Radiation Therapy? Cancer 2003; 98: 2378-83.[Crossref]
• Clayman G, Gonzalez HE, El-Naggar A et al.: Parathyroid Carcinoma: Evaluation and Interdisciplinary Management. Cancer 2004; 100: 900-05.[PubMed][Crossref]
• Rodgers SE, Perrier ND: Parathyroid carcinoma. Curr Opin Oncol 2006; 18: 16-22.[Crossref][PubMed]

Identifiers

DOI

10.2478/v10035-010-0014-0